Lucia Moiola Selected Research

Lucia Moiola Research Topics

Disease

48	Multiple Sclerosis 11/2022 - 06/2009
12	Relapsing-Remitting Multiple Sclerosis 10/2022 - 02/2014
11	COVID-19 10/2022 - 01/2021
8	Progressive Multifocal Leukoencephalopathy 01/2019 - 07/2014
4	Infections 10/2022 - 01/2021
4	Optic Neuritis (Retrobulbar Neuritis) 03/2022 - 12/2017
4	Atrophy 01/2020 - 07/2013
3	Inflammation (Inflammations) 01/2021 - 01/2020
3	Immune Reconstitution Inflammatory Syndrome 01/2019 - 07/2017
3	Disease Progression 11/2017 - 01/2016
2	Encephalitis (Encephalitis, Rasmussen) 03/2022 - 02/2019
2	Opportunistic Infections (Opportunistic Infection) 01/2022 - 01/2016
2	Pain (Aches) 01/2021 - 02/2016
2	Spontaneous Abortion (Miscarriage) 01/2018 - 10/2012
1	Myelitis 03/2022
1	Human Influenza (Influenza) 01/2022
1	Ganglion Cysts (Ganglion) 12/2021
1	Atrioventricular Block 11/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Hypersensitivity (Allergy) 11/2020
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 05/2020
1	Neutropenia 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2015
1	Neuromyelitis Optica (Devic's Disease) 03/2014
1	Chronic Progressive Multiple Sclerosis 12/2010
1	Marchiafava-Bignami Disease 02/2003

Drug/Important Bio-Agent (IBA)

21	Natalizumab (Tysabri)FDA Link 11/2022 - 07/2014
11	Fingolimod Hydrochloride (FTY720)FDA Link 10/2022 - 12/2015
7	Pharmaceutical PreparationsIBA 01/2021 - 12/2010
5	Interferon-betaIBA 01/2022 - 06/2009
4	nitazoxanide (NTZ)FDA Link 01/2022 - 03/2015
4	Glatiramer Acetate (Copaxone)FDA Link 09/2015 - 06/2009
3	ocrelizumabIBA 10/2022 - 01/2020
3	AntibodiesIBA 03/2022 - 01/2020
3	Cladribine FDA LinkGeneric 01/2022 - 01/2021
3	Oligoclonal BandsIBA 12/2021 - 12/2015
3	Retinaldehyde (Retinal)IBA 12/2021 - 12/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2012
2	Methylprednisolone FDA LinkGeneric 07/2022 - 01/2021
2	Rituximab (Mabthera)FDA Link 03/2022 - 01/2021
2	SuspensionsIBA 11/2021 - 01/2018
2	Alemtuzumab (Campath)FDA Link 12/2018 - 01/2017
1	N-acetyltalosaminuronic acid (NAT)IBA 11/2022
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	Antiviral Agents (Antivirals)IBA 10/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 03/2022
1	TabletsIBA 01/2022
1	VaccinesIBA 01/2022
1	GadoliniumIBA 12/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 11/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2021
1	CytokinesIBA 01/2021
1	InterferonsIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Dimethyl FumarateIBA 11/2020
1	Antiphospholipid AntibodiesIBA 01/2020
1	pembrolizumabIBA 12/2019
1	Daclizumab (Zenapax)FDA Link 02/2019
1	SteroidsIBA 11/2017
1	Maraviroc FDA Link 07/2017
1	nabiximols (Sativex)IBA 02/2016
1	Interferon beta-1a FDA Link 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	MS 28IBA 01/2016
1	LipopolysaccharidesIBA 12/2015
1	Neutralizing AntibodiesIBA 02/2014
1	MicroRNAs (MicroRNA)IBA 02/2012
1	Messenger RNA (mRNA)IBA 02/2012
1	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2010
1	Immunomodulating AgentsIBA 06/2009
1	VitaminsIBA 02/2003

Therapy/Procedure

14	Therapeutics 01/2022 - 02/2003
1	Retreatment 01/2022
1	Immunomodulation 01/2021
1	Cesarean Section (Caesarean Section) 08/2019
1	Telescopes 12/2017
1	Plasma Exchange 11/2017
1	Injections 01/2016
1	Hematopoietic Stem Cell Transplantation 03/2014
1	Treatment Delay 07/2013
1	Epidural Analgesia 12/2012